Tilray Brands (TLRY) Revenue Growth (3y) (2023 - 2026)
Tilray Brands (TLRY) Revenue Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.42 Bn | 87.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.91 Bn | 32.16 Bn | 1.97 Bn | 2.84% |
| 3 | Zoetis | 32.72 Bn | 30.78 Bn | 1.62 Bn | 4.19% |
| 4 | Takeda Pharmaceutical | 27.65 Bn | 23.59 Bn | 4.39 Bn | -4.46% |
| 5 | United Therapeutics | 23.11 Bn | 20.96 Bn | 648.10 Mn | 15.52% |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.30 Bn | 18.50 Bn | 1.16 Bn | -2.00% |
| 8 | Neurocrine Biosciences | 17.88 Bn | 16.56 Bn | 800.70 Mn | 24.66% |
| 9 | Elanco Animal Health | 12.65 Bn | 12.22 Bn | 785.00 Mn | 2.94% |
| 10 | Tilray Brands | 447.32 Mn | 387.13 Mn | 54.95 Mn | 12.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 12.40% |
| Nov 30, 2025 | 14.70% |
| Aug 31, 2025 | 10.99% |
| May 31, 2025 | 13.56% |
| Feb 28, 2025 | 6.95% |
| Nov 30, 2024 | 10.78% |
| Aug 31, 2024 | 5.99% |
| May 31, 2024 | 17.35% |
| Feb 29, 2024 | 14.98% |
| Nov 30, 2023 | 14.39% |
| Aug 31, 2023 | 14.63% |
| May 31, 2023 | 17.50% |